In addition, both the companies have announced a joint marketing initiative to increase sales of the device, by participating in US and Canadian dental shows as well as pediatric dental shows.

Milestone Scientific chief executive officer Leonard Osser said, "Having served the dental market for over 36 years, Aseptico is an ideal partner for Milestone as they currently market their products to over 150,000 dentists across the United States and Canada and have well established sales channels."

Aseptico president Glenn Kazen said the STA system, which represents the most advanced drug delivery system in the market, offers patients a truly pain free experience.

"In addition to enhancing the patient experience, the STA System provides distinct benefits to the dentists, including faster onset of profound anesthesia, which allows the dentist to see significantly more patients due to shorter waiting time for onset of anesthesia," Kazen added.

"Overall, we believe the STA System will resonate extremely well with new and existing dental customers and reinforces our commitment to providing our dental customers with exclusive access to the most advanced and effective products on the market."

Milestone said it is looking forward to work with Aseptico, as it enters the next phase of growth.